All Eyes on Australia | GenomeWeb

All Eyes on Australia

Though not legally binding in the US, the decision of the Australian court hearing the gene patent case similar to Myriad's might intellectually influence the US Supreme Court when it hears Myriad's appeal, according to Genomics Law Report's John Conley.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.